(Q42573934)

2 November 2017

Leishmania resistance to miltefosine associated with genetic marker (English)

1 reference

2 November 2017

1 reference

12

1 reference

2 November 2017

10

Jacques Le Bras

1 reference

2 November 2017

1

Sandrine Cojean

1 reference

2 November 2017

2

Sandrine Houzé

1 reference

2 November 2017

Djamel Haouchine

3

1 reference

2 November 2017

Françoise Huteau

4

1 reference

2 November 2017

Sylvie Lariven

5

1 reference

2 November 2017

Véronique Hubert

6

1 reference

2 November 2017

Florence Michard

7

1 reference

2 November 2017

Christian Bories

8

1 reference

2 November 2017

Francine Pratlong

9

1 reference

2 November 2017

Philippe Marie Loiseau

11

1 reference

2 November 2017

language of work or name

1 reference

1 April 2012

1 reference

Emerging Infectious Diseases

2 November 2017

1 reference

2 November 2017

18

1 reference

2 November 2017

4

1 reference

2 November 2017

704-706

1 reference

In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3309694

16 August 2018

Identifiers

DOI

10.3201/EID1804.110841

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

22469394

1 reference